statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	906
RU - Federazione Russa	216
IT - Italia	148
IE - Irlanda	130
SG - Singapore	120
CN - Cina	105
GB - Regno Unito	97
BR - Brasile	59
VN - Vietnam	58
HK - Hong Kong	41
SE - Svezia	40
DE - Germania	35
FR - Francia	34
UA - Ucraina	31
FI - Finlandia	22
ZA - Sudafrica	14
IN - India	13
KR - Corea	11
CA - Canada	8
AT - Austria	7
ES - Italia	7
MX - Messico	7
BE - Belgio	6
BD - Bangladesh	5
PL - Polonia	5
AU - Australia	3
NG - Nigeria	3
PK - Pakistan	3
AR - Argentina	2
CO - Colombia	2
CR - Costa Rica	2
EC - Ecuador	2
JP - Giappone	2
NL - Olanda	2
NP - Nepal	2
SA - Arabia Saudita	2
UZ - Uzbekistan	2
VE - Venezuela	2
AE - Emirati Arabi Uniti	1
BO - Bolivia	1
CH - Svizzera	1
CY - Cipro	1
CZ - Repubblica Ceca	1
DZ - Algeria	1
EG - Egitto	1
IL - Israele	1
IM - Isola di Man	1
IQ - Iraq	1
JM - Giamaica	1
JO - Giordania	1
KE - Kenya	1
KG - Kirghizistan	1
KH - Cambogia	1
LA - Repubblica Popolare Democratica del Laos	1
LB - Libano	1
LT - Lituania	1
LV - Lettonia	1
MA - Marocco	1
MU - Mauritius	1
PE - Perù	1
PT - Portogallo	1
RO - Romania	1
SN - Senegal	1
SY - Repubblica araba siriana	1
TH - Thailandia	1
TR - Turchia	1
Totale	2.182

Nome	#
Immunomodulatory properties of DNA hypomethylating agents: Selecting the optimal epigenetic partner for cancer immunotherapy	253
Circulating levels of PD-L1 in mesothelioma patients from the NIBIT-MESO-1 study: Correlation with survival	242
Fourteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) on Cancer Bio-Immunotherapy, Siena, Italy, October 13–15, 2016	236
Animal Resources and Subsistence Strategies	228
“Cancer Bio-Immunotherapy in Siena”: Thirteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 8–10, 2015	210
Fifteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) on Cancer Bio-Immunotherapy, Siena, Italy, October 5–7, 2017	204
Structure-fucntion relationship of the NDM-1 metallo-beta-lactamase: Importance of Trp-87 in enzyme structure, function and stability.	201
Identification of immune correlates of clinical activity and/or disease outcome in melanoma patients undergoing targeted therapy	194
SARS-CoV-2 infection in cancer patients on active therapy after the booster dose of mRNA vaccines	166
Severe acute respiratory syndrome coronavirus 2 vaccination and cancer therapy: A successful but mindful mix	115
The Italian Network for Tumor Bio-Immunotherapy (NIBIT) Foundation: ongoing and prospective activities in immuno-oncology	111
The Immunomodulatory Activity of Thymosin Alpha 1 on Tumor Cell Lines and Distinct Immune Cell Subsets	59
Totale	2.219

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	62	0	0	0	0	0	0	0	0	0	26	12	24
2021/2022	150	3	29	9	7	8	9	7	7	10	18	22	21
2022/2023	164	11	13	24	16	11	33	7	11	20	8	5	5
2023/2024	200	8	5	22	7	4	56	70	10	3	2	9	4
2024/2025	309	6	18	42	18	34	17	8	10	22	22	36	76
2025/2026	782	48	84	65	108	233	42	106	31	22	43	0	0
Totale													2.219